Thursday, May 11, 2017
Lunch Program
12:00 pm - Check-in & Lunch
12:15 pm-1:15 pm - Program

Hilton New Orleans Riverside
Room: Churchill D, 2nd Level
Two Poydras Street
New Orleans, LA 70130

Sponsored by the Cardiovascular Research Foundation
Supported through an educational grant from CHIESI USA, Inc. 

There is no cost to register. You must be a SCAI 2017 registrant
to attend these satellite programs.


The decision to use P2Y12 Inhibitors has been the cornerstone treatment of patients with acute coronary syndrome (ACS). Through case presentations, find out about optimal anti-platelet coverage in patients with NSTE- ACS and STEMI and the pharmacotherapy treatments. Gain valuable insight into the correct timing and modality of transition from intravenous to oral platelet inhibition in patients. Plus, learn vital tips from experts in the field to help you with the transition to oral P2Y12 receptor blockades.

Learning Objectives

At the end of this program, the attendees will be able to:

  • Gain important knowledge about transitioning from oral to intravenous P2Y12 receptor blockades and vice versa
  • Explore the use of anti-platelets in patients with NSTE and STEMI
  • Identify the optimal transition and treatment of patients with ACS

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is designed for interventional cardiologists, clinical cardiologists, and other healthcare professionals involved in the management of patients with cardiovascular disease.

Evaluation by questionnaire will address content, presentations, and future educational needs.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation, nor the course directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.

This program is sponsored by the Cardiovascular Research Foundation and supported through an educational grant from CHIESI USA, Inc. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.



Deepak L. Bhatt, MD, MPH, FSCAI Brigham and Women's Hospital
Boston, MA

Gregg W. Stone, MD, FSCAI NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY


David A. Cox, MD, FSCAI Lehigh Valley Hospital Network
Bethlehem, PA

Philippe Généreux, MD Gagnon Cardiovascular Institute/
Hôpital du Sacré-Coeur de Montréal
Morristown, NJ

C. Michael Gibson, MD, MS, FSCAI Beth Israel Deaconess Medical Center
Boston, MA

Roxana Mehran, MD, FSCAI Mount Sinai Medical Center
New York, NY



{{}} and {{lecturer}}, and {{case_presenter}},



{{}} and {{mod}},



{{}} and {{lecturer}}, and {{case_presenter}},


There is no cost to register. You must be a SCAI 2017 registrant to attend this satellite program.

Should you have any questions, please contact
Catherine Brosnan at

Register Now